nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—ABCB1—lung cancer	0.212	1	CbGaD
Amantadine—SLC22A2—Vinblastine—lung cancer	0.0585	0.156	CbGbCtD
Amantadine—SLC22A2—Cisplatin—lung cancer	0.0536	0.143	CbGbCtD
Amantadine—ABCB1—Topotecan—lung cancer	0.0359	0.0954	CbGbCtD
Amantadine—ABCB1—Gefitinib—lung cancer	0.0328	0.0872	CbGbCtD
Amantadine—ABCB1—Vinorelbine—lung cancer	0.0253	0.0672	CbGbCtD
Amantadine—ABCB1—Crizotinib—lung cancer	0.0201	0.0535	CbGbCtD
Amantadine—ABCB1—Gemcitabine—lung cancer	0.0196	0.0522	CbGbCtD
Amantadine—ABCB1—Erlotinib—lung cancer	0.0194	0.0516	CbGbCtD
Amantadine—ABCB1—Paclitaxel—lung cancer	0.0178	0.0472	CbGbCtD
Amantadine—ABCB1—Irinotecan—lung cancer	0.0175	0.0466	CbGbCtD
Amantadine—ABCB1—Vinblastine—lung cancer	0.0156	0.0414	CbGbCtD
Amantadine—ABCB1—Cisplatin—lung cancer	0.0143	0.038	CbGbCtD
Amantadine—ABCB1—Etoposide—lung cancer	0.014	0.0373	CbGbCtD
Amantadine—ABCB1—Docetaxel—lung cancer	0.0128	0.0341	CbGbCtD
Amantadine—ABCB1—Doxorubicin—lung cancer	0.00957	0.0254	CbGbCtD
Amantadine—ABCB1—Methotrexate—lung cancer	0.00927	0.0246	CbGbCtD
Amantadine—GRIN3B—lung—lung cancer	0.000289	0.178	CbGeAlD
Amantadine—Constipation—Irinotecan—lung cancer	0.000205	0.000922	CcSEcCtD
Amantadine—Mental disorder—Docetaxel—lung cancer	0.000205	0.000919	CcSEcCtD
Amantadine—Hypotension—Cisplatin—lung cancer	0.000204	0.000914	CcSEcCtD
Amantadine—Anxiety—Paclitaxel—lung cancer	0.000203	0.000914	CcSEcCtD
Amantadine—Malnutrition—Docetaxel—lung cancer	0.000203	0.000913	CcSEcCtD
Amantadine—Decreased appetite—Gemcitabine—lung cancer	0.000203	0.000913	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000203	0.000911	CcSEcCtD
Amantadine—Nausea—Topotecan—lung cancer	0.000202	0.000907	CcSEcCtD
Amantadine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000202	0.000906	CcSEcCtD
Amantadine—Fatigue—Gemcitabine—lung cancer	0.000201	0.000905	CcSEcCtD
Amantadine—Confusional state—Etoposide—lung cancer	0.000201	0.000904	CcSEcCtD
Amantadine—Cardiac arrest—Doxorubicin—lung cancer	0.0002	0.0009	CcSEcCtD
Amantadine—Constipation—Gemcitabine—lung cancer	0.0002	0.000898	CcSEcCtD
Amantadine—Nausea—Erlotinib—lung cancer	0.0002	0.000898	CcSEcCtD
Amantadine—Dry mouth—Paclitaxel—lung cancer	0.0002	0.000897	CcSEcCtD
Amantadine—Anaphylactic shock—Etoposide—lung cancer	0.0002	0.000896	CcSEcCtD
Amantadine—Diarrhoea—Vinorelbine—lung cancer	0.000199	0.000894	CcSEcCtD
Amantadine—Ataxia—Doxorubicin—lung cancer	0.000198	0.00089	CcSEcCtD
Amantadine—Feeling abnormal—Irinotecan—lung cancer	0.000198	0.000888	CcSEcCtD
Amantadine—Confusional state—Paclitaxel—lung cancer	0.000197	0.000886	CcSEcCtD
Amantadine—Neutropenia—Methotrexate—lung cancer	0.000197	0.000883	CcSEcCtD
Amantadine—Anaphylactic shock—Paclitaxel—lung cancer	0.000196	0.000879	CcSEcCtD
Amantadine—Oedema—Paclitaxel—lung cancer	0.000196	0.000879	CcSEcCtD
Amantadine—Paraesthesia—Cisplatin—lung cancer	0.000196	0.000879	CcSEcCtD
Amantadine—Tachycardia—Etoposide—lung cancer	0.000195	0.000875	CcSEcCtD
Amantadine—Liver function test abnormal—Doxorubicin—lung cancer	0.000194	0.000873	CcSEcCtD
Amantadine—Dyspnoea—Cisplatin—lung cancer	0.000194	0.000872	CcSEcCtD
Amantadine—Skin disorder—Etoposide—lung cancer	0.000194	0.000871	CcSEcCtD
Amantadine—Hyperhidrosis—Etoposide—lung cancer	0.000193	0.000867	CcSEcCtD
Amantadine—Feeling abnormal—Gemcitabine—lung cancer	0.000193	0.000865	CcSEcCtD
Amantadine—Dizziness—Vinorelbine—lung cancer	0.000192	0.000864	CcSEcCtD
Amantadine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000192	0.000864	CcSEcCtD
Amantadine—Nervous system disorder—Paclitaxel—lung cancer	0.000192	0.000862	CcSEcCtD
Amantadine—Photosensitivity reaction—Methotrexate—lung cancer	0.000192	0.000862	CcSEcCtD
Amantadine—Tachycardia—Paclitaxel—lung cancer	0.000191	0.000858	CcSEcCtD
Amantadine—Anorexia—Etoposide—lung cancer	0.00019	0.000855	CcSEcCtD
Amantadine—Skin disorder—Paclitaxel—lung cancer	0.00019	0.000854	CcSEcCtD
Amantadine—Body temperature increased—Irinotecan—lung cancer	0.00019	0.000852	CcSEcCtD
Amantadine—Decreased appetite—Cisplatin—lung cancer	0.000189	0.000851	CcSEcCtD
Amantadine—Hyperhidrosis—Paclitaxel—lung cancer	0.000189	0.00085	CcSEcCtD
Amantadine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000188	0.000845	CcSEcCtD
Amantadine—Anorexia—Paclitaxel—lung cancer	0.000187	0.000838	CcSEcCtD
Amantadine—Hypotension—Etoposide—lung cancer	0.000186	0.000838	CcSEcCtD
Amantadine—Vomiting—Vinorelbine—lung cancer	0.000185	0.000831	CcSEcCtD
Amantadine—Body temperature increased—Gemcitabine—lung cancer	0.000185	0.00083	CcSEcCtD
Amantadine—Rash—Vinorelbine—lung cancer	0.000183	0.000824	CcSEcCtD
Amantadine—Dermatitis—Vinorelbine—lung cancer	0.000183	0.000823	CcSEcCtD
Amantadine—Hypotension—Paclitaxel—lung cancer	0.000183	0.000821	CcSEcCtD
Amantadine—Headache—Vinorelbine—lung cancer	0.000182	0.000819	CcSEcCtD
Amantadine—Dysphagia—Doxorubicin—lung cancer	0.000182	0.000818	CcSEcCtD
Amantadine—Leukopenia—Docetaxel—lung cancer	0.000182	0.000817	CcSEcCtD
Amantadine—Palpitations—Docetaxel—lung cancer	0.00018	0.000807	CcSEcCtD
Amantadine—Feeling abnormal—Cisplatin—lung cancer	0.000179	0.000806	CcSEcCtD
Amantadine—Paraesthesia—Etoposide—lung cancer	0.000179	0.000805	CcSEcCtD
Amantadine—Dyspnoea—Etoposide—lung cancer	0.000178	0.000799	CcSEcCtD
Amantadine—Somnolence—Etoposide—lung cancer	0.000177	0.000797	CcSEcCtD
Amantadine—Insomnia—Paclitaxel—lung cancer	0.000177	0.000795	CcSEcCtD
Amantadine—Hypersensitivity—Irinotecan—lung cancer	0.000177	0.000794	CcSEcCtD
Amantadine—Convulsion—Docetaxel—lung cancer	0.000176	0.000791	CcSEcCtD
Amantadine—Paraesthesia—Paclitaxel—lung cancer	0.000176	0.000789	CcSEcCtD
Amantadine—Hypertension—Docetaxel—lung cancer	0.000175	0.000788	CcSEcCtD
Amantadine—Agranulocytosis—Methotrexate—lung cancer	0.000175	0.000786	CcSEcCtD
Amantadine—Dyspnoea—Paclitaxel—lung cancer	0.000174	0.000784	CcSEcCtD
Amantadine—Somnolence—Paclitaxel—lung cancer	0.000174	0.000781	CcSEcCtD
Amantadine—Decreased appetite—Etoposide—lung cancer	0.000173	0.000779	CcSEcCtD
Amantadine—Nausea—Vinorelbine—lung cancer	0.000173	0.000776	CcSEcCtD
Amantadine—Gastrointestinal disorder—Etoposide—lung cancer	0.000172	0.000774	CcSEcCtD
Amantadine—Dyspepsia—Paclitaxel—lung cancer	0.000172	0.000774	CcSEcCtD
Amantadine—Body temperature increased—Cisplatin—lung cancer	0.000172	0.000774	CcSEcCtD
Amantadine—Asthenia—Irinotecan—lung cancer	0.000172	0.000773	CcSEcCtD
Amantadine—Fatigue—Etoposide—lung cancer	0.000172	0.000773	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000172	0.000772	CcSEcCtD
Amantadine—Constipation—Etoposide—lung cancer	0.000171	0.000767	CcSEcCtD
Amantadine—Neutropenia—Doxorubicin—lung cancer	0.00017	0.000765	CcSEcCtD
Amantadine—Decreased appetite—Paclitaxel—lung cancer	0.00017	0.000764	CcSEcCtD
Amantadine—Dry mouth—Docetaxel—lung cancer	0.000169	0.00076	CcSEcCtD
Amantadine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000169	0.000759	CcSEcCtD
Amantadine—DDC—respiratory system—lung cancer	0.000169	0.104	CbGeAlD
Amantadine—Fatigue—Paclitaxel—lung cancer	0.000169	0.000758	CcSEcCtD
Amantadine—Asthenia—Gemcitabine—lung cancer	0.000168	0.000753	CcSEcCtD
Amantadine—Constipation—Paclitaxel—lung cancer	0.000167	0.000752	CcSEcCtD
Amantadine—Confusional state—Docetaxel—lung cancer	0.000167	0.000751	CcSEcCtD
Amantadine—Urinary tract disorder—Methotrexate—lung cancer	0.000166	0.000746	CcSEcCtD
Amantadine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000166	0.000746	CcSEcCtD
Amantadine—Oedema—Docetaxel—lung cancer	0.000166	0.000745	CcSEcCtD
Amantadine—Anaphylactic shock—Docetaxel—lung cancer	0.000166	0.000745	CcSEcCtD
Amantadine—Pruritus—Gemcitabine—lung cancer	0.000165	0.000743	CcSEcCtD
Amantadine—Urethral disorder—Methotrexate—lung cancer	0.000165	0.000741	CcSEcCtD
Amantadine—Feeling abnormal—Etoposide—lung cancer	0.000164	0.000739	CcSEcCtD
Amantadine—Diarrhoea—Irinotecan—lung cancer	0.000164	0.000737	CcSEcCtD
Amantadine—Nervous system disorder—Docetaxel—lung cancer	0.000163	0.000731	CcSEcCtD
Amantadine—Visual impairment—Methotrexate—lung cancer	0.000162	0.000728	CcSEcCtD
Amantadine—Tachycardia—Docetaxel—lung cancer	0.000162	0.000727	CcSEcCtD
Amantadine—Feeling abnormal—Paclitaxel—lung cancer	0.000161	0.000724	CcSEcCtD
Amantadine—Skin disorder—Docetaxel—lung cancer	0.000161	0.000724	CcSEcCtD
Amantadine—Hypersensitivity—Cisplatin—lung cancer	0.00016	0.000721	CcSEcCtD
Amantadine—Diarrhoea—Gemcitabine—lung cancer	0.00016	0.000718	CcSEcCtD
Amantadine—Dizziness—Irinotecan—lung cancer	0.000159	0.000713	CcSEcCtD
Amantadine—Anorexia—Docetaxel—lung cancer	0.000158	0.00071	CcSEcCtD
Amantadine—Body temperature increased—Etoposide—lung cancer	0.000158	0.000709	CcSEcCtD
Amantadine—Eye disorder—Methotrexate—lung cancer	0.000157	0.000706	CcSEcCtD
Amantadine—Asthenia—Cisplatin—lung cancer	0.000156	0.000702	CcSEcCtD
Amantadine—Cardiac disorder—Methotrexate—lung cancer	0.000156	0.000701	CcSEcCtD
Amantadine—Hypotension—Docetaxel—lung cancer	0.000155	0.000696	CcSEcCtD
Amantadine—Body temperature increased—Paclitaxel—lung cancer	0.000155	0.000695	CcSEcCtD
Amantadine—Angiopathy—Methotrexate—lung cancer	0.000153	0.000686	CcSEcCtD
Amantadine—Vomiting—Irinotecan—lung cancer	0.000153	0.000685	CcSEcCtD
Amantadine—Mediastinal disorder—Methotrexate—lung cancer	0.000152	0.000681	CcSEcCtD
Amantadine—Agranulocytosis—Doxorubicin—lung cancer	0.000151	0.00068	CcSEcCtD
Amantadine—Rash—Irinotecan—lung cancer	0.000151	0.00068	CcSEcCtD
Amantadine—Dermatitis—Irinotecan—lung cancer	0.000151	0.000679	CcSEcCtD
Amantadine—Headache—Irinotecan—lung cancer	0.00015	0.000675	CcSEcCtD
Amantadine—Insomnia—Docetaxel—lung cancer	0.00015	0.000674	CcSEcCtD
Amantadine—Diarrhoea—Cisplatin—lung cancer	0.000149	0.00067	CcSEcCtD
Amantadine—Paraesthesia—Docetaxel—lung cancer	0.000149	0.000669	CcSEcCtD
Amantadine—Alopecia—Methotrexate—lung cancer	0.000149	0.000668	CcSEcCtD
Amantadine—Vomiting—Gemcitabine—lung cancer	0.000149	0.000668	CcSEcCtD
Amantadine—Dyspnoea—Docetaxel—lung cancer	0.000148	0.000664	CcSEcCtD
Amantadine—Somnolence—Docetaxel—lung cancer	0.000147	0.000662	CcSEcCtD
Amantadine—Mental disorder—Methotrexate—lung cancer	0.000147	0.000662	CcSEcCtD
Amantadine—Rash—Gemcitabine—lung cancer	0.000147	0.000662	CcSEcCtD
Amantadine—Dermatitis—Gemcitabine—lung cancer	0.000147	0.000661	CcSEcCtD
Amantadine—Hypersensitivity—Etoposide—lung cancer	0.000147	0.00066	CcSEcCtD
Amantadine—Malnutrition—Methotrexate—lung cancer	0.000146	0.000658	CcSEcCtD
Amantadine—Headache—Gemcitabine—lung cancer	0.000146	0.000658	CcSEcCtD
Amantadine—Dyspepsia—Docetaxel—lung cancer	0.000146	0.000656	CcSEcCtD
Amantadine—Decreased appetite—Docetaxel—lung cancer	0.000144	0.000648	CcSEcCtD
Amantadine—Hypersensitivity—Paclitaxel—lung cancer	0.000144	0.000648	CcSEcCtD
Amantadine—Urinary tract disorder—Doxorubicin—lung cancer	0.000144	0.000646	CcSEcCtD
Amantadine—Oedema peripheral—Doxorubicin—lung cancer	0.000144	0.000645	CcSEcCtD
Amantadine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000143	0.000643	CcSEcCtD
Amantadine—Asthenia—Etoposide—lung cancer	0.000143	0.000643	CcSEcCtD
Amantadine—Fatigue—Docetaxel—lung cancer	0.000143	0.000642	CcSEcCtD
Amantadine—Urethral disorder—Doxorubicin—lung cancer	0.000143	0.000642	CcSEcCtD
Amantadine—Nausea—Irinotecan—lung cancer	0.000143	0.00064	CcSEcCtD
Amantadine—Constipation—Docetaxel—lung cancer	0.000142	0.000637	CcSEcCtD
Amantadine—Pruritus—Etoposide—lung cancer	0.000141	0.000634	CcSEcCtD
Amantadine—Visual impairment—Doxorubicin—lung cancer	0.00014	0.000631	CcSEcCtD
Amantadine—Asthenia—Paclitaxel—lung cancer	0.00014	0.000631	CcSEcCtD
Amantadine—Nausea—Gemcitabine—lung cancer	0.000139	0.000624	CcSEcCtD
Amantadine—Vomiting—Cisplatin—lung cancer	0.000138	0.000622	CcSEcCtD
Amantadine—Pruritus—Paclitaxel—lung cancer	0.000138	0.000622	CcSEcCtD
Amantadine—Vision blurred—Methotrexate—lung cancer	0.000138	0.00062	CcSEcCtD
Amantadine—Rash—Cisplatin—lung cancer	0.000137	0.000617	CcSEcCtD
Amantadine—Dermatitis—Cisplatin—lung cancer	0.000137	0.000616	CcSEcCtD
Amantadine—Feeling abnormal—Docetaxel—lung cancer	0.000137	0.000614	CcSEcCtD
Amantadine—Diarrhoea—Etoposide—lung cancer	0.000137	0.000613	CcSEcCtD
Amantadine—SIGMAR1—mammary gland—lung cancer	0.000136	0.084	CbGeAlD
Amantadine—Eye disorder—Doxorubicin—lung cancer	0.000136	0.000612	CcSEcCtD
Amantadine—Cardiac disorder—Doxorubicin—lung cancer	0.000135	0.000607	CcSEcCtD
Amantadine—Diarrhoea—Paclitaxel—lung cancer	0.000134	0.000601	CcSEcCtD
Amantadine—Angiopathy—Doxorubicin—lung cancer	0.000132	0.000594	CcSEcCtD
Amantadine—Dizziness—Etoposide—lung cancer	0.000132	0.000593	CcSEcCtD
Amantadine—Mediastinal disorder—Doxorubicin—lung cancer	0.000131	0.00059	CcSEcCtD
Amantadine—Body temperature increased—Docetaxel—lung cancer	0.000131	0.000589	CcSEcCtD
Amantadine—Leukopenia—Methotrexate—lung cancer	0.000131	0.000589	CcSEcCtD
Amantadine—Arrhythmia—Doxorubicin—lung cancer	0.00013	0.000585	CcSEcCtD
Amantadine—Dizziness—Paclitaxel—lung cancer	0.000129	0.000581	CcSEcCtD
Amantadine—Nausea—Cisplatin—lung cancer	0.000129	0.000581	CcSEcCtD
Amantadine—Alopecia—Doxorubicin—lung cancer	0.000129	0.000578	CcSEcCtD
Amantadine—Mental disorder—Doxorubicin—lung cancer	0.000128	0.000573	CcSEcCtD
Amantadine—Convulsion—Methotrexate—lung cancer	0.000127	0.00057	CcSEcCtD
Amantadine—Vomiting—Etoposide—lung cancer	0.000127	0.00057	CcSEcCtD
Amantadine—Malnutrition—Doxorubicin—lung cancer	0.000127	0.00057	CcSEcCtD
Amantadine—Rash—Etoposide—lung cancer	0.000126	0.000565	CcSEcCtD
Amantadine—Dermatitis—Etoposide—lung cancer	0.000126	0.000565	CcSEcCtD
Amantadine—Headache—Etoposide—lung cancer	0.000125	0.000562	CcSEcCtD
Amantadine—Tension—Doxorubicin—lung cancer	0.000124	0.000559	CcSEcCtD
Amantadine—Vomiting—Paclitaxel—lung cancer	0.000124	0.000559	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000124	0.000556	CcSEcCtD
Amantadine—Rash—Paclitaxel—lung cancer	0.000123	0.000554	CcSEcCtD
Amantadine—Dermatitis—Paclitaxel—lung cancer	0.000123	0.000554	CcSEcCtD
Amantadine—Nervousness—Doxorubicin—lung cancer	0.000123	0.000553	CcSEcCtD
Amantadine—Headache—Paclitaxel—lung cancer	0.000123	0.000551	CcSEcCtD
Amantadine—Hypersensitivity—Docetaxel—lung cancer	0.000122	0.000549	CcSEcCtD
Amantadine—Confusional state—Methotrexate—lung cancer	0.000121	0.000541	CcSEcCtD
Amantadine—Anaphylactic shock—Methotrexate—lung cancer	0.00012	0.000537	CcSEcCtD
Amantadine—Vision blurred—Doxorubicin—lung cancer	0.00012	0.000537	CcSEcCtD
Amantadine—Asthenia—Docetaxel—lung cancer	0.000119	0.000535	CcSEcCtD
Amantadine—Nausea—Etoposide—lung cancer	0.000119	0.000532	CcSEcCtD
Amantadine—Pruritus—Docetaxel—lung cancer	0.000117	0.000527	CcSEcCtD
Amantadine—Nervous system disorder—Methotrexate—lung cancer	0.000117	0.000527	CcSEcCtD
Amantadine—Agitation—Doxorubicin—lung cancer	0.000117	0.000524	CcSEcCtD
Amantadine—Nausea—Paclitaxel—lung cancer	0.000116	0.000522	CcSEcCtD
Amantadine—Skin disorder—Methotrexate—lung cancer	0.000116	0.000522	CcSEcCtD
Amantadine—Hyperhidrosis—Methotrexate—lung cancer	0.000116	0.000519	CcSEcCtD
Amantadine—Anorexia—Methotrexate—lung cancer	0.000114	0.000512	CcSEcCtD
Amantadine—Leukopenia—Doxorubicin—lung cancer	0.000114	0.00051	CcSEcCtD
Amantadine—Diarrhoea—Docetaxel—lung cancer	0.000113	0.00051	CcSEcCtD
Amantadine—Palpitations—Doxorubicin—lung cancer	0.000112	0.000503	CcSEcCtD
Amantadine—Hypotension—Methotrexate—lung cancer	0.000112	0.000502	CcSEcCtD
Amantadine—Convulsion—Doxorubicin—lung cancer	0.00011	0.000494	CcSEcCtD
Amantadine—Dizziness—Docetaxel—lung cancer	0.00011	0.000493	CcSEcCtD
Amantadine—Hypertension—Doxorubicin—lung cancer	0.000109	0.000492	CcSEcCtD
Amantadine—Insomnia—Methotrexate—lung cancer	0.000108	0.000486	CcSEcCtD
Amantadine—Anxiety—Doxorubicin—lung cancer	0.000108	0.000483	CcSEcCtD
Amantadine—Paraesthesia—Methotrexate—lung cancer	0.000107	0.000482	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000107	0.000482	CcSEcCtD
Amantadine—Dyspnoea—Methotrexate—lung cancer	0.000107	0.000479	CcSEcCtD
Amantadine—Somnolence—Methotrexate—lung cancer	0.000106	0.000477	CcSEcCtD
Amantadine—Dry mouth—Doxorubicin—lung cancer	0.000106	0.000474	CcSEcCtD
Amantadine—Vomiting—Docetaxel—lung cancer	0.000105	0.000474	CcSEcCtD
Amantadine—Dyspepsia—Methotrexate—lung cancer	0.000105	0.000473	CcSEcCtD
Amantadine—Rash—Docetaxel—lung cancer	0.000105	0.00047	CcSEcCtD
Amantadine—Dermatitis—Docetaxel—lung cancer	0.000104	0.000469	CcSEcCtD
Amantadine—Confusional state—Doxorubicin—lung cancer	0.000104	0.000469	CcSEcCtD
Amantadine—Decreased appetite—Methotrexate—lung cancer	0.000104	0.000467	CcSEcCtD
Amantadine—Headache—Docetaxel—lung cancer	0.000104	0.000467	CcSEcCtD
Amantadine—Oedema—Doxorubicin—lung cancer	0.000104	0.000465	CcSEcCtD
Amantadine—Anaphylactic shock—Doxorubicin—lung cancer	0.000104	0.000465	CcSEcCtD
Amantadine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000103	0.000464	CcSEcCtD
Amantadine—Fatigue—Methotrexate—lung cancer	0.000103	0.000463	CcSEcCtD
Amantadine—Nervous system disorder—Doxorubicin—lung cancer	0.000102	0.000456	CcSEcCtD
Amantadine—Tachycardia—Doxorubicin—lung cancer	0.000101	0.000454	CcSEcCtD
Amantadine—Skin disorder—Doxorubicin—lung cancer	0.000101	0.000452	CcSEcCtD
Amantadine—Hyperhidrosis—Doxorubicin—lung cancer	0.0001	0.00045	CcSEcCtD
Amantadine—Anorexia—Doxorubicin—lung cancer	9.87e-05	0.000443	CcSEcCtD
Amantadine—Nausea—Docetaxel—lung cancer	9.85e-05	0.000443	CcSEcCtD
Amantadine—Feeling abnormal—Methotrexate—lung cancer	9.85e-05	0.000443	CcSEcCtD
Amantadine—Hypotension—Doxorubicin—lung cancer	9.67e-05	0.000434	CcSEcCtD
Amantadine—Body temperature increased—Methotrexate—lung cancer	9.45e-05	0.000424	CcSEcCtD
Amantadine—Insomnia—Doxorubicin—lung cancer	9.36e-05	0.000421	CcSEcCtD
Amantadine—Paraesthesia—Doxorubicin—lung cancer	9.29e-05	0.000418	CcSEcCtD
Amantadine—Dyspnoea—Doxorubicin—lung cancer	9.23e-05	0.000415	CcSEcCtD
Amantadine—Somnolence—Doxorubicin—lung cancer	9.2e-05	0.000413	CcSEcCtD
Amantadine—Dyspepsia—Doxorubicin—lung cancer	9.11e-05	0.000409	CcSEcCtD
Amantadine—Decreased appetite—Doxorubicin—lung cancer	9e-05	0.000404	CcSEcCtD
Amantadine—DDC—lung—lung cancer	8.96e-05	0.0553	CbGeAlD
Amantadine—Gastrointestinal disorder—Doxorubicin—lung cancer	8.94e-05	0.000401	CcSEcCtD
Amantadine—Fatigue—Doxorubicin—lung cancer	8.92e-05	0.000401	CcSEcCtD
Amantadine—Constipation—Doxorubicin—lung cancer	8.85e-05	0.000398	CcSEcCtD
Amantadine—Hypersensitivity—Methotrexate—lung cancer	8.81e-05	0.000396	CcSEcCtD
Amantadine—MAOB—respiratory system—lung cancer	8.69e-05	0.0536	CbGeAlD
Amantadine—Asthenia—Methotrexate—lung cancer	8.58e-05	0.000385	CcSEcCtD
Amantadine—Feeling abnormal—Doxorubicin—lung cancer	8.53e-05	0.000383	CcSEcCtD
Amantadine—Pruritus—Methotrexate—lung cancer	8.46e-05	0.00038	CcSEcCtD
Amantadine—Body temperature increased—Doxorubicin—lung cancer	8.18e-05	0.000368	CcSEcCtD
Amantadine—Diarrhoea—Methotrexate—lung cancer	8.18e-05	0.000367	CcSEcCtD
Amantadine—Dizziness—Methotrexate—lung cancer	7.9e-05	0.000355	CcSEcCtD
Amantadine—Hypersensitivity—Doxorubicin—lung cancer	7.63e-05	0.000343	CcSEcCtD
Amantadine—Vomiting—Methotrexate—lung cancer	7.6e-05	0.000341	CcSEcCtD
Amantadine—Rash—Methotrexate—lung cancer	7.54e-05	0.000339	CcSEcCtD
Amantadine—Dermatitis—Methotrexate—lung cancer	7.53e-05	0.000338	CcSEcCtD
Amantadine—Headache—Methotrexate—lung cancer	7.49e-05	0.000336	CcSEcCtD
Amantadine—SIGMAR1—bronchus—lung cancer	7.47e-05	0.0461	CbGeAlD
Amantadine—Asthenia—Doxorubicin—lung cancer	7.43e-05	0.000334	CcSEcCtD
Amantadine—DRD2—respiratory system—lung cancer	7.33e-05	0.0452	CbGeAlD
Amantadine—Pruritus—Doxorubicin—lung cancer	7.32e-05	0.000329	CcSEcCtD
Amantadine—MAOB—bronchus—lung cancer	7.15e-05	0.0441	CbGeAlD
Amantadine—Nausea—Methotrexate—lung cancer	7.1e-05	0.000319	CcSEcCtD
Amantadine—Diarrhoea—Doxorubicin—lung cancer	7.08e-05	0.000318	CcSEcCtD
Amantadine—Dizziness—Doxorubicin—lung cancer	6.84e-05	0.000307	CcSEcCtD
Amantadine—SIGMAR1—trachea—lung cancer	6.71e-05	0.0414	CbGeAlD
Amantadine—Vomiting—Doxorubicin—lung cancer	6.58e-05	0.000296	CcSEcCtD
Amantadine—Rash—Doxorubicin—lung cancer	6.53e-05	0.000293	CcSEcCtD
Amantadine—Dermatitis—Doxorubicin—lung cancer	6.52e-05	0.000293	CcSEcCtD
Amantadine—Headache—Doxorubicin—lung cancer	6.48e-05	0.000291	CcSEcCtD
Amantadine—SIGMAR1—cardiac atrium—lung cancer	6.3e-05	0.0388	CbGeAlD
Amantadine—Nausea—Doxorubicin—lung cancer	6.15e-05	0.000276	CcSEcCtD
Amantadine—DDC—lymph node—lung cancer	6.13e-05	0.0378	CbGeAlD
Amantadine—MAOB—cardiac atrium—lung cancer	6.03e-05	0.0372	CbGeAlD
Amantadine—SIGMAR1—bone marrow—lung cancer	5.32e-05	0.0328	CbGeAlD
Amantadine—SIGMAR1—lung—lung cancer	4.82e-05	0.0297	CbGeAlD
Amantadine—MAOB—lung—lung cancer	4.61e-05	0.0284	CbGeAlD
Amantadine—DRD2—lung—lung cancer	3.89e-05	0.024	CbGeAlD
Amantadine—SIGMAR1—lymph node—lung cancer	3.3e-05	0.0203	CbGeAlD
Amantadine—ABCB1—respiratory system—lung cancer	3.17e-05	0.0195	CbGeAlD
Amantadine—MAOB—lymph node—lung cancer	3.15e-05	0.0195	CbGeAlD
Amantadine—ABCB1—epithelium—lung cancer	2.65e-05	0.0163	CbGeAlD
Amantadine—ABCB1—trachea—lung cancer	2.34e-05	0.0144	CbGeAlD
Amantadine—SLC22A2—Metabolism—CYP2A6—lung cancer	1.92e-05	0.000102	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—HRAS—lung cancer	1.91e-05	0.000102	CbGpPWpGaD
Amantadine—DDC—Metabolism—CREBBP—lung cancer	1.9e-05	0.000101	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ADCY1—lung cancer	1.9e-05	0.000101	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ABCG2—lung cancer	1.9e-05	0.000101	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.9e-05	0.000101	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOA1—lung cancer	1.89e-05	0.000101	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PGAM1—lung cancer	1.89e-05	0.000101	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—lung cancer	1.89e-05	0.000101	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—HRAS—lung cancer	1.87e-05	9.95e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HPGDS—lung cancer	1.86e-05	9.92e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ENO2—lung cancer	1.86e-05	9.92e-05	CbGpPWpGaD
Amantadine—ABCB1—bone marrow—lung cancer	1.86e-05	0.0115	CbGeAlD
Amantadine—SLC22A1—Metabolism—PPP2R1B—lung cancer	1.85e-05	9.86e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.85e-05	9.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.84e-05	9.82e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—IL6—lung cancer	1.83e-05	9.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PXN—lung cancer	1.82e-05	9.72e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ENO1—lung cancer	1.82e-05	9.67e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—CREBBP—lung cancer	1.81e-05	9.67e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTT1—lung cancer	1.81e-05	9.62e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AVP—lung cancer	1.81e-05	9.62e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CD—lung cancer	1.8e-05	9.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2A7—lung cancer	1.8e-05	9.6e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—IL6—lung cancer	1.79e-05	9.52e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.79e-05	9.52e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GRP—lung cancer	1.79e-05	9.52e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKR1C1—lung cancer	1.79e-05	9.52e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—OXTR—lung cancer	1.79e-05	9.52e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP2A6—lung cancer	1.79e-05	9.51e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GCLC—lung cancer	1.79e-05	9.51e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.78e-05	9.5e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—ALB—lung cancer	1.78e-05	9.49e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SDC4—lung cancer	1.76e-05	9.39e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CG—lung cancer	1.73e-05	9.2e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—lung cancer	1.73e-05	9.2e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.7e-05	9.06e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ALB—lung cancer	1.7e-05	9.05e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ENO1—lung cancer	1.69e-05	9.02e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—AKT1—lung cancer	1.69e-05	9.01e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.69e-05	9.01e-05	CbGpPWpGaD
Amantadine—ABCB1—lung—lung cancer	1.68e-05	0.0104	CbGeAlD
Amantadine—DRD2—Signaling Pathways—GNG11—lung cancer	1.67e-05	8.91e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.65e-05	8.81e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—AKT1—lung cancer	1.65e-05	8.78e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—POMC—lung cancer	1.64e-05	8.76e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CXCL8—lung cancer	1.64e-05	8.75e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AVP—lung cancer	1.64e-05	8.74e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP2E1—lung cancer	1.63e-05	8.68e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NQO1—lung cancer	1.61e-05	8.58e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.61e-05	8.58e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—RRM1—lung cancer	1.61e-05	8.56e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTA3—lung cancer	1.61e-05	8.56e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CREBBP—lung cancer	1.6e-05	8.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFC—lung cancer	1.59e-05	8.48e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ALB—lung cancer	1.58e-05	8.43e-05	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—HRAS—lung cancer	1.57e-05	8.38e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CB—lung cancer	1.57e-05	8.38e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—lung cancer	1.56e-05	8.3e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—RAF1—lung cancer	1.54e-05	8.18e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.53e-05	8.16e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.52e-05	8.12e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CD—lung cancer	1.52e-05	8.09e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP2E1—lung cancer	1.52e-05	8.09e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—B4GALT5—lung cancer	1.51e-05	8.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADCY1—lung cancer	1.5e-05	8.01e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NQO1—lung cancer	1.5e-05	8e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALB—lung cancer	1.5e-05	7.99e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.48e-05	7.89e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTA4—lung cancer	1.47e-05	7.82e-05	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—HRAS—lung cancer	1.47e-05	7.81e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SMARCA4—lung cancer	1.47e-05	7.81e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP2R1B—lung cancer	1.47e-05	7.81e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—STK11—lung cancer	1.45e-05	7.73e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.45e-05	7.72e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	1.43e-05	7.63e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTA2—lung cancer	1.43e-05	7.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HSPB1—lung cancer	1.41e-05	7.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTHLH—lung cancer	1.4e-05	7.45e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTA1—lung cancer	1.38e-05	7.36e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.37e-05	7.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ABCC3—lung cancer	1.37e-05	7.27e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTEN—lung cancer	1.36e-05	7.24e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—STK11—lung cancer	1.35e-05	7.21e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTP1—lung cancer	1.34e-05	7.16e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CB—lung cancer	1.32e-05	7.05e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKR1C1—lung cancer	1.32e-05	7.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ANXA1—lung cancer	1.31e-05	7e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—lung cancer	1.31e-05	6.99e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CAT—lung cancer	1.31e-05	6.96e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—EP300—lung cancer	1.3e-05	6.9e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—UGT1A1—lung cancer	1.28e-05	6.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FLT1—lung cancer	1.27e-05	6.78e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ABCB1—lung cancer	1.27e-05	6.77e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CG—lung cancer	1.26e-05	6.72e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.26e-05	6.7e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTP1—lung cancer	1.25e-05	6.67e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TYMS—lung cancer	1.25e-05	6.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH3—lung cancer	1.25e-05	6.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APP—lung cancer	1.25e-05	6.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNG11—lung cancer	1.24e-05	6.59e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGF9—lung cancer	1.24e-05	6.58e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTM1—lung cancer	1.23e-05	6.58e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CAT—lung cancer	1.22e-05	6.49e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.22e-05	6.48e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—POMC—lung cancer	1.2e-05	6.39e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ABCB1—lung cancer	1.19e-05	6.31e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—JUNB—lung cancer	1.18e-05	6.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALDOA—lung cancer	1.18e-05	6.28e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.17e-05	6.24e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP1A1—lung cancer	1.17e-05	6.23e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TYMS—lung cancer	1.16e-05	6.2e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ERCC2—lung cancer	1.16e-05	6.18e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTM1—lung cancer	1.15e-05	6.13e-05	CbGpPWpGaD
Amantadine—ABCB1—lymph node—lung cancer	1.15e-05	0.0071	CbGeAlD
Amantadine—DRD2—Signaling by GPCR—PIK3CG—lung cancer	1.15e-05	6.1e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NCOA3—lung cancer	1.14e-05	6.1e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTEN—lung cancer	1.14e-05	6.09e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ADCY1—lung cancer	1.11e-05	5.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ABCG2—lung cancer	1.11e-05	5.93e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CD—lung cancer	1.11e-05	5.91e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HPGDS—lung cancer	1.09e-05	5.82e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ENO2—lung cancer	1.09e-05	5.82e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—EP300—lung cancer	1.09e-05	5.81e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP1A1—lung cancer	1.09e-05	5.81e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—POMC—lung cancer	1.09e-05	5.81e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPP2R1B—lung cancer	1.08e-05	5.78e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ERCC2—lung cancer	1.08e-05	5.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STK11—lung cancer	1.07e-05	5.71e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6R—lung cancer	1.06e-05	5.66e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTT1—lung cancer	1.06e-05	5.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCLC—lung cancer	1.05e-05	5.58e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2A6—lung cancer	1.05e-05	5.58e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FOXO3—lung cancer	1.03e-05	5.51e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.03e-05	5.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MAP2K1—lung cancer	1.01e-05	5.4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CD—lung cancer	1.01e-05	5.36e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOA1—lung cancer	1e-05	5.35e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ENO1—lung cancer	9.92e-06	5.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	9.91e-06	5.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AVP—lung cancer	9.69e-06	5.16e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CB—lung cancer	9.66e-06	5.15e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CA—lung cancer	9.59e-06	5.11e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOA1—lung cancer	9.36e-06	4.99e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1R—lung cancer	9.33e-06	4.97e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CXCL8—lung cancer	9.29e-06	4.95e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	9.28e-06	4.94e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CG—lung cancer	9.17e-06	4.88e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HES1—lung cancer	9.16e-06	4.88e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—RAF1—lung cancer	8.99e-06	4.79e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2E1—lung cancer	8.9e-06	4.74e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—IL2—lung cancer	8.88e-06	4.73e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NQO1—lung cancer	8.8e-06	4.69e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CB—lung cancer	8.78e-06	4.67e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—POMC—lung cancer	8.73e-06	4.65e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CG—lung cancer	8.55e-06	4.55e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CREBBP—lung cancer	8.5e-06	4.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CXCL8—lung cancer	8.43e-06	4.49e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	8.39e-06	4.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB3—lung cancer	8.38e-06	4.46e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—POMC—lung cancer	8.13e-06	4.33e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CA—lung cancer	8.07e-06	4.3e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CD—lung cancer	8.06e-06	4.29e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL2—lung cancer	8.06e-06	4.29e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TERT—lung cancer	8.03e-06	4.28e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALB—lung cancer	7.96e-06	4.24e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—STK11—lung cancer	7.93e-06	4.23e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CREBBP—lung cancer	7.92e-06	4.22e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKT1—lung cancer	7.83e-06	4.17e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGFR1—lung cancer	7.8e-06	4.15e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HIF1A—lung cancer	7.68e-06	4.09e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CD—lung cancer	7.51e-06	4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALB—lung cancer	7.42e-06	3.95e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOA1—lung cancer	7.41e-06	3.95e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KDR—lung cancer	7.34e-06	3.91e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTP1—lung cancer	7.34e-06	3.91e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CAT—lung cancer	7.14e-06	3.8e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CB—lung cancer	7.03e-06	3.74e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—lung cancer	6.96e-06	3.71e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TYMS—lung cancer	6.82e-06	3.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CG—lung cancer	6.77e-06	3.6e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KIT—lung cancer	6.77e-06	3.6e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APC—lung cancer	6.77e-06	3.6e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NRAS—lung cancer	6.77e-06	3.6e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTM1—lung cancer	6.75e-06	3.59e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGF—lung cancer	6.69e-06	3.56e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKT1—lung cancer	6.59e-06	3.51e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CB—lung cancer	6.55e-06	3.49e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—lung cancer	6.49e-06	3.46e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MAPK3—lung cancer	6.48e-06	3.45e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—POMC—lung cancer	6.44e-06	3.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP1A1—lung cancer	6.39e-06	3.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—BRAF—lung cancer	6.36e-06	3.39e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ERCC2—lung cancer	6.34e-06	3.38e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6R—lung cancer	6.28e-06	3.35e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CREBBP—lung cancer	6.27e-06	3.34e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EGFR—lung cancer	6.16e-06	3.28e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTEN—lung cancer	6.07e-06	3.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAP2K1—lung cancer	5.99e-06	3.19e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CD—lung cancer	5.95e-06	3.17e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	5.89e-06	3.14e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—KRAS—lung cancer	5.82e-06	3.1e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—EP300—lung cancer	5.79e-06	3.08e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTEN—lung cancer	5.66e-06	3.01e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA1—lung cancer	5.49e-06	2.92e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—EP300—lung cancer	5.4e-06	2.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CA—lung cancer	5.35e-06	2.85e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MDM2—lung cancer	5.33e-06	2.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RAF1—lung cancer	5.31e-06	2.83e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB2—lung cancer	5.25e-06	2.8e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MTOR—lung cancer	5.18e-06	2.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CB—lung cancer	5.18e-06	2.76e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CG—lung cancer	5.01e-06	2.67e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL8—lung cancer	4.98e-06	2.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HRAS—lung cancer	4.95e-06	2.64e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT1—lung cancer	4.81e-06	2.56e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CASP3—lung cancer	4.77e-06	2.54e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—POMC—lung cancer	4.77e-06	2.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL2—lung cancer	4.76e-06	2.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—lung cancer	4.74e-06	2.52e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CREBBP—lung cancer	4.64e-06	2.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCND1—lung cancer	4.64e-06	2.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—JUN—lung cancer	4.63e-06	2.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—lung cancer	4.51e-06	2.4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN1A—lung cancer	4.49e-06	2.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTEN—lung cancer	4.48e-06	2.39e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CD—lung cancer	4.4e-06	2.35e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT1—lung cancer	4.37e-06	2.33e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALB—lung cancer	4.35e-06	2.32e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CA—lung cancer	4.28e-06	2.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EP300—lung cancer	4.27e-06	2.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SRC—lung cancer	4.15e-06	2.21e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—lung cancer	4.05e-06	2.16e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STAT3—lung cancer	4.01e-06	2.13e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NRAS—lung cancer	4e-06	2.13e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CA—lung cancer	3.99e-06	2.13e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CB—lung cancer	3.84e-06	2.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK3—lung cancer	3.83e-06	2.04e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—lung cancer	3.8e-06	2.03e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MYC—lung cancer	3.72e-06	1.98e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGFR—lung cancer	3.64e-06	1.94e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKT1—lung cancer	3.5e-06	1.86e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KRAS—lung cancer	3.44e-06	1.83e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTEN—lung cancer	3.32e-06	1.77e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKT1—lung cancer	3.26e-06	1.74e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—EP300—lung cancer	3.16e-06	1.68e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CA—lung cancer	3.16e-06	1.68e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—lung cancer	3.06e-06	1.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRAS—lung cancer	2.92e-06	1.56e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—lung cancer	2.8e-06	1.49e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT1—lung cancer	2.58e-06	1.38e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CA—lung cancer	2.34e-06	1.25e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKT1—lung cancer	1.91e-06	1.02e-05	CbGpPWpGaD
